Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells
Cell Reports · 2026-06 · 45 (6) · 117510
DOI: 10.1016/j.celrep.2026.117510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026-06. Verfasst von Brian H Shim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA; Department of Chemistry and Ch…. Hauptthemen laut MEDLINE: Gene Editing, Peptides, Major Histocompatibility Complex, CD8-Positive T-Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA; Howard Hughes…
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Koch Institute for Integrative Cancer Research, Cambridge, MA, USA; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA…
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NHGRI NIH HHS
- Center for Advanced Materials Processing, Clarkson University
- Prime Minister's Office Singapore
- Bill and Melinda Gates Foundation
- Singapore-MIT Alliance for Research and Technology Centre
- MIT Koch Institute
Zitieren
APA
Shim, B. H., Zhao, Q. H., Queenan, J. A., Smith, B. E., Birnbaum, M. E., & Liu, D. R. (2026). Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells. Cell Reports, 45(6), 117510. https://doi.org/10.1016/j.celrep.2026.117510
Vancouver
Shim BH, Zhao QH, Queenan JA, Smith BE, Birnbaum ME, Liu DR. Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells. Cell Reports. 2026;45(6):117510. doi:10.1016/j.celrep.2026.117510
BibTeX
@article{Shim2026,
author = {Shim, Brian H and Zhao, Q Henry and Queenan, Jack A and Smith, Blake E and Birnbaum, Michael E and Liu, David R},
title = {Peptide-MHC-targeted engineered virus-like particles enable selective priming and gene editing of tumor-specific T cells},
journal = {Cell Reports},
year = {2026},
volume = {45},
number = {6},
pages = {117510},
doi = {10.1016/j.celrep.2026.117510}
}
EUVIMED